Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Medical Device - detail

REALQUALITY RQ-2019-nCoV

Manufactured by AB ANALITICA, Italy - www.abanalitica.com 

Device identification number
2093
CE Marking
Yes
HSC common list
×No
HSC mutual recognition
×No
Format
Automated, Manual, Semi-automated
Target
Nucleic acid
Specimen
Nasopharyngeal swab, Oropharyngeal swab
Commercial Status
Commercialised
Last Update
2021-05-27 01:48:50 CET
Comments
Kit for detection of RdRp and E genes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by one-step Real-Time RT PCR; Specimens: Nasopharyngeal swab Oropharyngeal swabs; Target: RdRp, E genes and Internal Control; No cross-reactivity confirmed with other respiratory pathogens including SARS, MERS and SARS-related viruses; Diagnostic specificity 100% Diagnostic sensitivity 98% Accuracy 99%
Assay Type
Nucleic acid-PCR
Method
RT-PCR
Time
100 minutes
LOD
4.69 AU
Positive control
Positive control 2019-nCoV (DNA containing part of the SARS-CoV-2 genome and IC RNA)
Accuracy
99 %
Clinical Sensitivity
98 %
Clinical Specificity
100 %

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements